3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
11
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Sleep Wake Disorders
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Anxiety Disorders
1
Interventions
Fluorouracil
74
Leucovorin
48
Oxaliplatin
44
Cisplatin
40
Capecitabine
39
Gemcitabine
37
Radiotherapy
30
Irinotecan
28
Cetuximab
21
Paclitaxel
15
Bevacizumab
12
Docetaxel
10
Taxes
9
durvalumab
8
dehydroftorafur
8
Surgical Procedures, Operative
8
Mitomycin
8
Specimen Handling
7
Platinum
7
Folfox protocol
7
Carboplatin
7
Albumin-Bound Paclitaxel
7
130-nm albumin-bound paclitaxel
7
S 1 (combination)
6
Panitumumab
6
Watchful Waiting
5
Imatinib Mesylate
5
Gene Expression Profiling
5
Epirubicin
5
tremelimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Exercise Test
×
Gastrointestinal
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts